Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05148234
Title A Phase I/II Trial of BMS-986253 in Myelodysplastic Syndromes
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

myelodysplastic syndrome

Therapies

BMS-986253 + Decitabine and Cedazuridine

BMS-986253

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.